Martin Quibell

Inga fler pågående positioner

Health Technology

Consumer Services

Profil

Martin Quibell is the founder and Chief Scientific Officer at Pedanius Therapeutics Ltd. which is founded in 2018.
He previously held positions as Director-Medicinal Chemistry at Acambis Plc, Vice President-Medicinal Chemistry at Amura Holdings Ltd. and Amura Therapeutics Ltd., and Principal at Incenta Ltd. Dr. Quibell earned a doctorate degree from the University of Birmingham in 1991 and an undergraduate degree from the University of Portsmouth.

Tidigare kända positioner av Martin Quibell

Företag	Position	Slut
Incenta Ltd.	Företagsledare/Principal	-
Amura Therapeutics Ltd.	Företagsledare/Principal	-
Acambis Plc Acambis Plc BiotechnologyHealth Technology Develops biopharmaceutical products and vaccines	Företagsledare/Principal	-
Amura Holdings Ltd. Amura Holdings Ltd. Pharmaceuticals: MajorHealth Technology Offers therapeutic drug research and development	Teknisk/Vetenskaplig/F&U Direktör	-

Se detaljerna i Martin Quibells erfarenhet

Martin Quibells utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Martin Quibells erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	6
Acambis Plc Acambis Plc BiotechnologyHealth Technology Develops biopharmaceutical products and vaccines	Health Technology
University of Birmingham University of Birmingham Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Portsmouth University of Portsmouth Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Amura Holdings Ltd. Amura Holdings Ltd. Pharmaceuticals: MajorHealth Technology Offers therapeutic drug research and development	Health Technology
Amura Therapeutics Ltd.
Incenta Ltd.